Weighing in on weight-based secukinumab dosing for psoriasis

Br J Dermatol. 2022 Jul;187(1):10-11. doi: 10.1111/bjd.21607. Epub 2022 May 16.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Humans
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab